Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1997 Nov;110(2):317–323. doi: 10.1111/j.1365-2249.1997.tb08334.x

Human serum mannose-binding lectin (MBL)-associated serine protease-1 (MASP-1): determination of levels in body fluids and identification of two forms in serum

I TERAI *, K KOBAYASHI *, M MATSUSHITA †, T FUJITA †
PMCID: PMC2265511  PMID: 9367419

Abstract

We developed an ELISA for human serum MASP-1, a Cls-like serine protease which is known to function in C4 and C2 activation. We then determined MASP-1 levels in 1063 sera from normal Japanese subjects ranging in age from 3 to 100 years, as well as in certain body fluids using this assay. Individual serum MASP-1 levels ranged from 148 to 12–83 μg/ml, with a normal frequency distribution pattern. The arithmetic mean ± s.d. of MASP-1 levels in serum was 6–27 ± 185 μg/ml, whereas levels of MASP-1 in cerebrospinal fluid and in urine were almost undetectable. When the mean ± s.d. of serum MASP-1 was calculated for each age group (10 year range) and values were then compared, the age group consisting of 3–9-year-olds (7–54 ± l-39;μ/ml) was found to have the highest value. When MASP-1 was measured in cord blood, it was shown that levels were already as high as those of 3–9-year-olds. The serum MASP-1 level was found to be as strongly dependent on age as is the serum MBL level. MASP-1 and MBL are thought to play an active part in immunity in younger people. It was found that the serum level of MASP-1 was much higher than that of MBL, and the major portion of human serum MASP-1 appeared to exist in the circulation as a form unbound to MBL.

Keywords: serum lectin, mannose-binding protein, complement activation, lectin pathway, ELISA

Full Text

The Full Text of this article is available as a PDF (654.0 KB).

References

  • 1.Kawasaki N, Kawasaki T, Yamashina I. A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity. J Biochem. 1989;106:483–9. doi: 10.1093/oxfordjournals.jbchem.a122878. [DOI] [PubMed] [Google Scholar]
  • 2.Kawasaki N, Kawasaki T, Yamashina I. Isolation and characterization of a mannan binding protein from human serum. J Biochem. 1983;94:937–47. doi: 10.1093/oxfordjournals.jbchem.a134437. [DOI] [PubMed] [Google Scholar]
  • 3.Holmskov U, Malhotra R, Sim RB, Jensenius JC. Collectins: collagenous C-type lectins of the innate immune defence system. Immunol Today. 1994;15:67–74. doi: 10.1016/0167-5699(94)90136-8. [DOI] [PubMed] [Google Scholar]
  • 4.Ezekowitz RA, Kuhlman M, Groopman JE, Byrn RA. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med. 1989;169:185–96. doi: 10.1084/jem.169.1.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kuhlman M, Joiner K, Ezekowitz RA. The human mannose-binding protein functions as an opsonin. J Exp Med. 1989;169:1733–45. doi: 10.1084/jem.169.5.1733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ikeda K, Sannoh T, Kawasaki N, Kawasaki T, Yamashina I. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem. 1987;262:7451–4. [PubMed] [Google Scholar]
  • 7.Ohta M, Okada M, Yamashina I, Kawasaki T. The mechanism of carbohydrate-mediated complement activation by the serum mannose binding protein. J Biol Chem. 1990;265:1980–4. [PubMed] [Google Scholar]
  • 8.Lu J, Thiel S, Wiedemann H, Timpl R, Reid KBM. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme Clr2Cls2 complex, of the classical pathway of complement, without involvement of Clq. J Immunol. 1990;144:2287–94. [PubMed] [Google Scholar]
  • 9.Super M, Levinsky RJ, Turner MW. The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low concentrations. Clin Exp Immunol. 1990;79:144–50. doi: 10.1111/j.1365-2249.1990.tb05170.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ohta M, Kawasaki T. Complement-dependent cytotoxic activity of serum mannan-binding protein towards mammalian cells with surface-exposed high-mannose type glycans. Glycoconjugate J. 1994;11:304–8. doi: 10.1007/BF00731203. [DOI] [PubMed] [Google Scholar]
  • 11.Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet. 1989;ii:1236–9. doi: 10.1016/s0140-6736(89)91849-7. [DOI] [PubMed] [Google Scholar]
  • 12.Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, Turner MW, Summerfield JA. Molecular basis of opsonic defect in immunodeficient children. Lancet. 1991;337:1569–70. doi: 10.1016/0140-6736(91)93263-9. [DOI] [PubMed] [Google Scholar]
  • 13.Turner MW. Deficiency of mannan binding protein–a new complement deficiency syndrome. Clin Exp Immunol. 1991;86(Suppl. 1):3–56. doi: 10.1111/j.1365-2249.1991.tb06208.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lipscombe RJ, Lau YL, Levinsky RJ, Sumiya M, Summerfield JA, Turner MW. Identical point mutation leading to low levels of mannose binding protein and poor C3b mediated opsonisation in Chinese and Caucasian populations. Immunol Letters. 1992;32:253–8. doi: 10.1016/0165-2478(92)90058-v. [DOI] [PubMed] [Google Scholar]
  • 15.Summerfield JA, Ryder S, Sumiya M, Thursz M, Gorchen A, Monteil MA, Turner MW. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet. pp. B886–9. [DOI] [PubMed]
  • 16.Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel Cls-like serine protease. J Exp Med. 1992;176:1497–502. doi: 10.1084/jem.176.6.1497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sato T, Endo Y, Matsushita M, Fujita T. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. Int Immunol. 1994;6:665–9. doi: 10.1093/intimm/6.4.665. [DOI] [PubMed] [Google Scholar]
  • 18.Takada F, Takayama Y, Hatsuse H, Kawakami M. A new member of the CIs family of complement proteins found in a bactericidal factor, Ra-reactive factor, in human serum. Biochem Biophys Res Commun. 1993;196:1003–9. doi: 10.1006/bbrc.1993.2349. [DOI] [PubMed] [Google Scholar]
  • 19.Thiel S. Mannose-binding protein, a complement activating animal lectin. Immunopharmacology. 1992;24:91–99. doi: 10.1016/0162-3109(92)90015-5. [DOI] [PubMed] [Google Scholar]
  • 20.Ji YH, Fujita T, Hatsuse H, Takahashi A, Matsushita M, Kawakami M. Activation oftheC4andC2 components of complement by a proteinase in serum bactericidal factor, Ra reactive factor. J Immunol. 1993;150:571–8. [PubMed] [Google Scholar]
  • 21.Matsushita M, Fujita T. Cleavage of the component of complement (C3) by mannose-binding protein-associated serine protease (MASP) with subsequent complement activation. Immunobiol. 1995;194:443–8. doi: 10.1016/S0171-2985(11)80110-5. [DOI] [PubMed] [Google Scholar]
  • 22.Terai I, Kobayashi K, Matsushita M, Fujita T, Matsuno K. α2-Macro-globulin binds to and inhibits mannose-binding protein associated serine protease (MASP) Int Immunol. 1995;7:1579–84. doi: 10.1093/intimm/7.10.1579. [DOI] [PubMed] [Google Scholar]
  • 23.Thiel S, Jensen TV, Stover CM, et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature. 1997;386:506–10. doi: 10.1038/386506a0. [DOI] [PubMed] [Google Scholar]
  • 24.Matsushita M, Ezekowitz RAB, Fujita T. The Gly-54→Asp allelic form of human mannosse-binding protein (MBP) fails to bind MBP-associated serine protease. Biochem J. 1995;311:1021–3. doi: 10.1042/bj3111021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Matsushita M, Takahashi A, Hatsuse H, Kawakami M, Fujita T. Human mannose-binding protein is identical to a component of Ra-reactive factor. Biochem Biophys Res Commun. 1992;183:645–51. doi: 10.1016/0006-291x(92)90531-o. [DOI] [PubMed] [Google Scholar]
  • 26.Wetlaufer DB. Ultraviolet spectra of proteins and amino acids. In: Anfinsen CB Jr, Anson ML, Bailey K, et al., editors. Advances in protein chemistry. Vol. 17. New York: Academic Press; 1962. pp. 303–90. [Google Scholar]
  • 27.Terai I, Kobayashi K, Fujita T, Hagiwara K. Human serum mannose binding protein (MBP): development of an enzyme-linked immunosorbent assay (ELISA) and determination of levels in serum from 1085 normal Japanese and in some body fluids. Biochem Med Metabol Biol. 1993;50:111–9. doi: 10.1006/bmmb.1993.1052. [DOI] [PubMed] [Google Scholar]
  • 28.Terai I, Kobayashi K. Perinatal changes in serum mannose-binding protein (MBP) levels. Immunol Letters. 1993;38:185–7. doi: 10.1016/0165-2478(93)90004-l. [DOI] [PubMed] [Google Scholar]
  • 29.Aittoniemi J, Miettinen A, Laipala P, Isolauri E, Viilari J, Ruuska T, Soppi E. Age-dependent variation in the serum concentration of mannan-binding protein. Acta Paediatr. 1996;85:906–9. doi: 10.1111/j.1651-2227.1996.tb14182.x. [DOI] [PubMed] [Google Scholar]
  • 30.Lau YL, Chan SY, Turner MW, Fong J, Karlberg J. Mannose-binding protein in preterm infants: developmental profile and clinical significance. Clin Exp Immunol. 1995;102:649–54. doi: 10.1111/j.1365-2249.1995.tb03866.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Thiel S, Bjerke T, Hansen D, Poulsen LK, SchØ PO, Jensenius JC. Ontogeny of human mannan-binding protein, a lectin of the innate immune system. Pediatr Allergy Immunol. 1995;6:20–23. doi: 10.1111/j.1399-3038.1995.tb00252.x. [DOI] [PubMed] [Google Scholar]
  • 32.Malhotra R, Willis AC, Bernal AL, Thiel S, Sim RB. Mannan-binding protein levels in human amniotic fluid during gestation and its interaction with collectin receptor from amnion cells. Immunology. 1994;82:439–44. [PMC free article] [PubMed] [Google Scholar]
  • 33.Kilpatrick DC, Bevan BH, Liston WA. Association between mannan binding protein deficiency and recurrent miscarriage. Hum Reprod. 1995;10:2501–5. doi: 10.1093/oxfordjournals.humrep.a136330. [DOI] [PubMed] [Google Scholar]
  • 34.Endo Y, Sato T, Matsushita M, Fujita T. Exon structure of the gene encoding the human mannose-binding protein-associated serine protease light chain: comparison with complement Clr and Cls genes. Int Immunol. 1996;8:1355–8. doi: 10.1093/intimm/8.9.1355. [DOI] [PubMed] [Google Scholar]
  • 35.Ihara S, Takahashi A, Hatsuse H, Sumitomo K, Doi K, Kawakami M. Major component of Ra-reactive factor, a complement-activating bactericidal protein, in mouse serum. J Immunol. 1991;146:1874–9. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES